Clinical Trial Update: Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) [Phase 2]

View source ↗

Summary

A randomized Phase II trial (FORMULA-509) in prostate cancer is evaluating salvage radiation therapy plus androgen deprivation therapy with or without adding ab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Apalutamide (apalutamide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING